심혈관 디지털 솔루션 시장 : 서비스별, 구성요소별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2023-2032년)

Cardiovascular Digital Solutions Market By Service, By Component, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 8,096,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,564,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

심혈관 디지털 솔루션 시장은 2022년 844억 달러로 평가되었고, 2023년부터 2032년까지 연평균 6.2% 성장하여 2032년에는 1,541억 달러에 달할 것으로 추정됩니다.

심혈관 디지털 솔루션은 심장 관련 질환의 예방, 진단, 모니터링, 관리 등 심혈관 건강의 다양한 측면을 해결하기 위해 고안된 기술 기반 도구 및 플랫폼을 말합니다. 심혈관 디지털 솔루션은 디지털 기술을 활용하여 환자 치료를 강화하고 결과를 개선하며 의료 전문가에게 귀중한 통찰력을 제공합니다. 이러한 솔루션은 모바일 앱, 웨어러블 기기, 원격 의료 플랫폼, 인공지능(AI), 데이터 분석, 원격 모니터링 등의 기술을 활용하여 심혈관 질환을 앓고 있는 개인에게 보다 효율적이고 효과적인 의료 서비스를 제공합니다.

심혈관 디지털 솔루션 시장은 특히 고혈압, 심근경색, 뇌졸중과 같은 심장 질환의 유병률 증가, 의료 서비스 제공업체와 환자의 디지털 기술 채택 급증, 원격 환자 모니터링의 기술 발전으로 인해 주도되고 있습니다. 심혈관 질환의 유병률 증가는 심혈관 디지털 솔루션 시장의 중요한 촉진요인으로 부상하고 있습니다. 관상동맥질환, 심부전, 뇌졸중 등 심혈관 질환은 세계적으로 이환율과 사망률의 주요 원인이 되고 있습니다. 미국 질병예방통제센터(CDC)에 따르면, 2021년 미국에서 약 695,000명이 심장 질환으로 사망할 것으로 추정됩니다. 또한 관상 동맥 심장 질환은 가장 흔한 심장 질환으로 2021년에 37만 5,476명이 사망할 것으로 예상됩니다. 심혈관 관리에 대한 전통적인 접근 방식은 종종 의료 시설에 대한 정기적인 방문에 의존하는 경우가 많아 종합적인 모니터링과 적시에 개입하기에 불충분할 수 있습니다. 반면, 디지털 솔루션은 웨어러블 기기나 센서를 통해 심박수, 혈압, 산소 농도 등 생체 신호를 지속적으로 모니터링할 수 있습니다. 이러한 지속적인 모니터링은 이상 징후를 조기에 발견하여 적시에 개입을 용이하게 하고, 부작용의 위험을 줄일 수 있습니다. 따라서 심혈관 질환의 유병률 증가는 심혈관 디지털 솔루션 시장의 주요 촉진요인으로 작용할 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 시장에 대한 COVID-19의 영향 분석

제4장 심혈관 디지털 솔루션 시장 : 서비스별

• 개요
• 비침습적 검사
• 심혈관 디지털 헬스 인포매틱스
• 심장 재활치료 프로그램

제5장 심혈관 디지털 솔루션 시장 : 컴포넌트별

• 개요
• 기기
• 소프트웨어

제6장 심혈관 디지털 솔루션 시장 : 최종사용자별

• 개요
• 의료 조직
• 의료 소비자
• 기타

제7장 심혈관 디지털 솔루션 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 호주
  • 인도
  • 한국
  • 기타
• 라틴아메리카/중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2022년

제9장 기업 개요

• iRhythm Technologies, Inc.
• Apple Inc.
• General Electric
• AlivCor, Inc.
• Verily Life Sciences LLC
• HeartFlow, Inc
• Koninklijke Philips N.V.
• Cardiac Insight Inc.
• Baxter International Inc.
• Murata Manufacturing Co., Ltd.

LSH

영문 목차

영문목차

According to a new report published by Allied Market Research, titled, "Cardiovascular Digital Solutions Market," The cardiovascular digital solutions market was valued at $84.4 billion in 2022, and is estimated to reach $154.1 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032. Cardiovascular digital solutions refer to technology-based tools and platforms designed to address various aspects of cardiovascular health, including prevention, diagnosis, monitoring, and management of heart-related conditions. Cardiovascular digital solutions leverage digital technologies to enhance patient care, improve outcomes, and provide healthcare professionals with valuable insights. These solutions leverage technology such as mobile apps, wearable devices, telemedicine platforms, artificial intelligence (AI), data analytics, and remote monitoring to provide more efficient and effective healthcare services for individuals with cardiovascular conditions.

The cardiovascular digital solutions market is driven by rising prevalence of cardiac diseases such as hypertension, cardiac arrythmia, stroke among others, surge in adoption of digital technologies by healthcare providers and patients and technological advancements in remote patient monitoring. The rising prevalence of cardiovascular disease has emerged as a significant driver for the cardiovascular digital solutions market. Cardiovascular disease, including conditions such as coronary artery disease, heart failure, and stroke, continues to be a leading cause of morbidity and mortality worldwide. According to Center for Disease Control and Prevention, in 2021, it was estimated that about 695,000 people in the U.S. died from heart disease. Furthermore, the coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Traditional approaches to cardiovascular care often rely on periodic visits to healthcare facilities, which may not be sufficient for comprehensive monitoring and timely intervention. Digital solutions, on the other hand, enable continuous monitoring of vital signs, such as heart rate, blood pressure, and oxygen levels, through wearable devices or sensors. This continuous monitoring allows for early detection of any abnormalities or warning signs, facilitating timely intervention and reducing the risk of adverse events. Thus, the rise in prevalence of cardiovascular disorders is expected to act as a major driver for cardiovascular digital solutions market.

In addition, the rise in adoption of digital technologies such as wearable devices have emerged as a significant driver for the cardiovascular digital solutions market. The integration of advanced digital tools and technologies in the healthcare industry has revolutionized the way cardiovascular diseases are diagnosed, treated, and managed. Furthermore, several hospitals and other healthcare facilities adopted cardiac patches for remote patient monitoring. In March 2021, North Bristol NHS Trust (NBT), a National Health Service, adopted Zio by iRhythm (leading digital health care company) in its cardiology and stroke departments. North Bristol NHS Trust (NBT) evaluated and compared four months of data from cardiology patients using Holter devices pre-Covid with four months of data from patients using Zio patches post-Covid. The evaluation shows that use of the Zio service has resulted in a decrease in waiting times for monitoring. Furthermore, the staff time requirements in the Zio pathway are only 33% as that of the traditional methods (Holter monitors). Thus, the rise in adoption of digital technologies such as wearable devices for cardiac monitoring by healthcare providers and patients is expected to drive the growth of the market.

Furthermore, the technological advancement in remote patient monitoring is expected to drive the growth of the market. For instance, KardiaMobile 6L by AliveCor, a leading medical device, is a portable medical device that enables individuals to monitor their heart health easily and conveniently at home. It is a compact, FDA-cleared, and clinically validated electrocardiogram (EKG) device designed to be used with compatible smartphones or tablets. Thus, the technological advancement in remote patient monitoring leads to better diagnosis and patient monitoring at home, resulting in the growth of the market.

However, high implementation costs of cardiac devices might act as a restraint for the growth of the market. On the other hand, integration of artificial intelligence in cardiac monitoring devices is expected to serve as a growth opportunity in the cardiology digital solutions market.

The cardiovascular digital solutions market is segmented on the basis of service, component, end user and region. By service, the market is categorized into unobtrusive monitoring, CVD health informatics, and cardiac rehabilitation programs. By component, the market is categorized into devices and software. On the basis of end user, the market is categorized into healthcare organization, healthcare consumer, and others. The others include govt institute, payer. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global cardiovascular digital solutions market AlivCor, Inc, Apple Inc., General Electric, Verily Life Sciences LLC, Koninklijke Philips N.V., HeartFlow, Inc, iRhythm Technologies, Inc., Baxter International Inc, Cardiac Insight Inc., and Cardiac Insight Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiovascular digital solutions market analysis from 2022 to 2032 to identify the prevailing cardiovascular digital solutions market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cardiovascular digital solutions market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cardiovascular digital solutions market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• Product Benchmarking / Product specification and applications
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Service

• Unobtrusive Testing
• CVD Health Informatics
• Cardiac Rehab Programs

By Component

• Devices
• Software

By End User

• Healthcare organization
• Healthcare consumer
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Verily Life Sciences LLC
• iRhythm Technologies, Inc.
• Murata Manufacturing Co., Ltd.
• Cardiac Insight Inc.
• Apple Inc.
• AlivCor, Inc.
• HeartFlow, Inc
• Koninklijke Philips N.V.
• Baxter International Inc.
• General Electric

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of cardiovascular disorders.
    • 3.4.1.2. Surge in adoption of digital technology in healthcare.
    • 3.4.1.3. Technological advancement in remote patient monitoring.

• 3.4.2. Restraints
  • 3.4.2.1. High implementation costs

• 3.4.3. Opportunities
  • 3.4.3.1. Integration of artificial intelligence in cardiac devices

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Unobtrusive Testing
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. CVD Health Informatics
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Cardiac Rehab Programs
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Devices
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Software
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Healthcare organization
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Healthcare consumer
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Service
  • 7.2.3. Market size and forecast, by Component
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Service
    • 7.2.5.1.2. Market size and forecast, by Component
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Service
    • 7.2.5.2.2. Market size and forecast, by Component
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Service
    • 7.2.5.3.2. Market size and forecast, by Component
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Service
  • 7.3.3. Market size and forecast, by Component
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Service
    • 7.3.5.1.2. Market size and forecast, by Component
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Service
    • 7.3.5.2.2. Market size and forecast, by Component
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Service
    • 7.3.5.3.2. Market size and forecast, by Component
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Service
    • 7.3.5.4.2. Market size and forecast, by Component
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Service
    • 7.3.5.5.2. Market size and forecast, by Component
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Service
    • 7.3.5.6.2. Market size and forecast, by Component
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Service
  • 7.4.3. Market size and forecast, by Component
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Service
    • 7.4.5.1.2. Market size and forecast, by Component
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Service
    • 7.4.5.2.2. Market size and forecast, by Component
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Market size and forecast, by Service
    • 7.4.5.3.2. Market size and forecast, by Component
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. India
    • 7.4.5.4.1. Market size and forecast, by Service
    • 7.4.5.4.2. Market size and forecast, by Component
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Service
    • 7.4.5.5.2. Market size and forecast, by Component
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Service
    • 7.4.5.6.2. Market size and forecast, by Component
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Service
  • 7.5.3. Market size and forecast, by Component
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Service
    • 7.5.5.1.2. Market size and forecast, by Component
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Service
    • 7.5.5.2.2. Market size and forecast, by Component
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Service
    • 7.5.5.3.2. Market size and forecast, by Component
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Service
    • 7.5.5.4.2. Market size and forecast, by Component
    • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. iRhythm Technologies, Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Apple Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. General Electric
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
  • 9.3.0. Key strategic moves and developments
• 9.4. AlivCor, Inc.
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.0. Key strategic moves and developments
• 9.5. Verily Life Sciences LLC
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
• 9.6. HeartFlow, Inc
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.0. Key strategic moves and developments
• 9.7. Koninklijke Philips N.V.
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.0. Key strategic moves and developments
• 9.8. Cardiac Insight Inc.
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.0. Key strategic moves and developments
• 9.9. Baxter International Inc.
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
  • 9.9.0. Key strategic moves and developments
• 9.10. Murata Manufacturing Co., Ltd.
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance

관련자료